Last reviewed · How we verify
E. Coli Pyelonephritis
Approved treatments
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug. - Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis. - Cystadane · Recordati
- Cefepim · University Hospital Tuebingen
- Ciprofloxacine · Poitiers University Hospital
- Zymar · Allergan
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Noroxin
- Floxin
- Cipro · Bayer AG
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Cystadane · Mayo Clinic
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- E. Coli Pyelonephritis patent landscape — cliff calendar, originator estates, attackable patents
- E. Coli Pyelonephritis treatment landscape brief
- E. Coli Pyelonephritis treatment updates RSS
Frequently asked questions about E. Coli Pyelonephritis
What drugs treat E. Coli Pyelonephritis?
Tracked treatments include Maxipime, Cystadane, Cefepim, Ciprofloxacine, Zymar, Invanz, Noroxin, Floxin.
What is the treatment for E. Coli Pyelonephritis?
Standard treatment for E. Coli Pyelonephritis includes Maxipime, Cystadane, Cefepim, Ciprofloxacine, Zymar. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: E. Coli Pyelonephritis patent cliff · E. Coli Pyelonephritis CI report
- Treatment: Maxipime · Baxter
- Treatment: Maxipime · Baxter
- Treatment: Cystadane · Recordati
- Treatment: Cefepim · University Hospital Tuebingen
- Treatment: Ciprofloxacine · Poitiers University Hospital
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing